Wall Street’s Key Stock Analysts Research Report, All Buys
#stocks #bullish #buys #analysts #research #WallStreet
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy if you can manage the risk.
These are all Buys if you can manage the risk.
Below are our Buys for Wednesday 19 May, as follows:
Alliant Energy Corp. (NYSE:LNT): Mizuho upgraded the shares to Buy from Neutral and also raised the price target to 61. The consensus target is at 58.56.
Arena Pharmaceuticals Inc. (NASDAQ:ARNA): Goldman Sachs started coverage with a Buy rating and a 90 price target. That compares to a 98.07 Street consensus.
CASI Pharmaceuticals Inc. (NASDAQ:CASI): BTIG started coverage with a Buy rating and a 4 price target. The consensus is at 4.27.
Pool Corp. (NASDAQ:POOL): Goldman Sachs started coverage with a Buy rating and a 535 price target. The consensus price objective is at 441.71.
Snowflake Inc. (NASDAQ:SNOW): Rosenblatt raised its rating to Buy from Neutral and has a $285 price target. The consensus price objective is set higher at $296.77.
Have a healthy day, Keep the Faith!
Palantir Stock (PLTR): BUY Rating, $250 Price Target — The 40% Dislocation
Palantir is down ~40% in 2026 even as Q1 revenue grew 85% and management guided FY2026 to $7.66B. Shayne Heffernan issues a BUY on PLTR with a $250 price target — full breakdown of the business, customers, five-year revenue, every major Wall Street bank target and the corporate outlook.
Larry Fink Called It. CME Just Made It Real. The Compute Futures Market Has Arrived
The Quantum-AI Convergence Is Real. The Quantum Stocks Aren't the Trade.
China’s Economic Resilience
Every story, signed and delivered.
Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.